https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-28 13:48:112024-12-28 13:53:04Targeting LIG1 with PARP Inhibitors: E New Target Identified Using CRISPR
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-26 08:46:292024-12-25 22:08:05New Nanoparticle Therapy Holds Promise for Prostate Cancer Patients
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-26 08:20:232024-12-25 22:07:47Repurposing FDA-Approved Drugs for PIM-1 Kinase Inhibition: A Potential Avenue for Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-26 08:06:312024-12-25 22:07:12Xaluritamig (AMG 509): Promising Updates on a STEAP1-Targeted Therapy for Advanced Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-23 16:14:062024-12-23 16:14:06Phase 1 trial: AVA6000 Targeted Chemotherapy for FAP-Positive Tumors (Including Prostate Cancer)
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-23 15:50:092024-12-23 15:50:09Phase 1 trial of QXL138AM: A Targeted Therapy for Prostate Cancer and Other CD138-Expressing Tumors
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-23 15:04:112024-12-23 15:04:11Phase 1 trial of INV-9956: A Promising CYP11A1 Inhibitor Targeting Drug-Resistant Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-22 08:51:152024-12-22 08:51:15Phase 1 Enrolling: Novel Copper-61 Radiotracer Shows Promise in Prostate Cancer Precision Imaging 